| 78492 | In this diagnostic procedure, the provider performs a myocardial perfusion PET imaging study which means it reveals the flow of oxygenated blood to the heart muscles. The service also includes… | 170 | $1,600 | $278.4K |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 350 | $420 | $145.1K |
| 93229 | In this procedure, the provider, typically a technician, places a wearable electrocardiographic monitoring device on the patient, instructs him in its use, and monitors the transmissions, to detect… | 150 | $950 | $138.3K |
| 33285 | The provider inserts a cardiac rhythm monitor with self–contained electrodes into a pocket in the tissues beneath the patient's skin and programs the device according to manufacturer’s directions. | 20 | $4,960 | $99.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 860 | $110 | $98.3K |
| 93306 | The provider uses transducers to obtain two–dimensional (2D) images of the heart structures through the chest wall. He evaluates the anatomy and function of all four heart chambers, valves, adjacent… | 340 | $160 | $55.4K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system,… | 700 | $70 | $45.8K |
| 93280 | In this service, the provider performs a face to face evaluation and then optimally adjusts the existing parameters of an already implanted dual lead pacemaker system. He changes various operating… | 250 | $80 | $19.7K |
| J2785 | Injection, regadenoson, 0.1 mg | 460 | $40 | $18.7K |
| 99454 | The provider supplies one or more devices for remote physiologic monitoring that occurs for 16 to 30 days in a 30–day period. | 340 | $50 | $17.6K |